Shankaran, Veena

IFN-γ–related mRNA profile predicts clinical response to PD-1 blockade

Ayers, M., Lunceford, J., Nebozhyn, M., Murphy, E., Loboda, A., Kaufman, D. R., Albright, A., Cheng, J. D., Kang, S. P., Shankaran, V., et al. (2017) · Journal of Clinical Investigation

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 3,788

KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas

Diehl, A. C., Hannan, L. M., Zhen, D. B., Coveler, A. L., King, G., Cohen, S. A., Harris, W. P., Shankaran, V., Wong, K. M., Green, S., et al. (2022) · The Oncologist

Pancreatic and Hepatic Oncology ResearchCancer Genomics and Diagnostics

Cited by 35

Costs and Cost-Effectiveness of a Low-Intensity Patient-Directed Intervention to Promote Colorectal Cancer Screening

Shankaran, V., McKoy, J. M., Dandade, N., Nonzee, N., Tigue, C. A., Bennett, C. L., & Denberg, T. D. (2007) · Journal of Clinical Oncology

Colorectal Cancer Screening and DetectionGlobal Cancer Incidence and Screening

Cited by 34

Association of major adverse financial events and later-stage cancer diagnosis in the United States.

Warren, J. L., Mariotto, A. B., Stevens, J., Davidoff, A. J., Shankaran, V., Ward, K. C., Wu, X.-C., Schwartz, S. M., Penberthy, L., & Yabroff, K. R. (2024) · Journal of Clinical Oncology

Global Cancer Incidence and ScreeningEconomic and Financial Impacts of Cancer

Cited by 7